Andrea Necchi on TAR-200 plus cetrelimab as neoadjuvant therapy in patients with muscle-invasive bladder cancer

de The Lancet Oncology in conversation with

  • 2025-09-29 22:00:00Fecha de lanzamiento
  • 12:15Duración